Safety-first guide
GLP-1 side effects: common symptoms, red flags and support
Side effects vary by molecule, product, individual and medical context. This page separates routine education from symptoms that should receive urgent medical attention.
Commonly discussed symptoms
Nausea, vomiting, diarrhoea, constipation, reflux, reduced appetite and abdominal discomfort are frequently discussed with incretin-based medicines.
Even a common symptom can become clinically important if it is severe, persistent or prevents eating and drinking.
When to contact the prescribing doctor
Contact the clinician for symptoms that are worsening, recurring, interfering with hydration or nutrition, or causing uncertainty about continuing treatment.
Do not independently change medicine, combine products or alter treatment instructions based on internet content.
Urgent red flags
Seek urgent medical care for severe or persistent abdominal pain, repeated vomiting with inability to keep fluids down, signs of severe dehydration, fainting, breathing difficulty, confusion or rapid deterioration.
ZentraHealth WhatsApp support is not an emergency service. Do not wait for a reply if symptoms may be urgent.
- Use local emergency services or the nearest appropriate emergency facility.
- Take your medicine list and relevant clinical information.
- Tell the treating team when symptoms began and how they changed.
What structured support can and cannot do
SideEffect Guard™ can help users track symptoms, prepare questions and recognise escalation boundaries.
It cannot diagnose the cause of a symptom, replace examination or make medication changes.
Frequently asked questions
Are all GLP-1 side effects mild?
No. Many symptoms may be manageable, but serious problems can occur. Severity and persistence matter.
Can WhatsApp support handle an emergency?
No. Seek urgent medical care and do not wait for a WhatsApp response.
Should I stop medicine because of a side effect?
Contact the prescribing doctor for individual advice. This page cannot tell you to start, stop or alter a prescription medicine.
References and source material
These sources support the educational context on this page. Product labels and recommendations can change; local medical evaluation remains essential.
- Wegovy (semaglutide) prescribing information — U.S. Food and Drug Administration
- Zepbound (tirzepatide) prescribing information — U.S. Food and Drug Administration
Continue with the route that fits your situation
Use the suitability guide if you are still researching, or activate structured support when you are ready. Payment never guarantees a prescription or medical suitability.